Publications found:
37,045
Sort by:
Cancer Vaccines & Circulating Tumor Cells (CTCs) 2011 Report
US$ 2,649.00
... Biosciences presents a comprehensive industry analysis of the cancer vaccines space as well as that of the emerging circulating tumor cells (CTCs) space. These two ... This report also examines the technology and market landscape for circulating tumor cells (CTCs). There is currently much interest in CTCs as they ...
December 2010
139 pages
Epigenetics Market Trends 2011
US$ 1,655.00
... Market Quantitative Segmentation by type of Modification Studied Epigenetics Market Segmentation by Type of HDAC Studied Penetrance of Product Vendors into Various Segments of the Epigenetics Marketplace: Quantitative Analysis Emerging Trends and Themes in Epigenetics Current Studies of microRNAs, non- ...
December 2010
76 pages
Global Pharmaceutical & Biotechnology Outlook 2011
US$ 10,000.00
... strategic and long term investment decision making of senior management. Outlook-11’ has been tailored to deliver more meaningfully in the ... for the future, and their key milestones. The Global Pharmaceutical Model is changing. Major pharmaceutical companies continue to under-perform in a market constrained ...
December 2010
454 pages
Pharma YouTube Channels: Content and Comment
US$ 395.00
Popular video sharing site YouTube is the third busiest website in the world, visited by almost 109 million unique users each month. Nearly a day and a half's worth of content is uploaded by users on...
December 2010
81 pages
CNS Clinical Trials: World Market Prospects 2011-2026
US$ 2,325.00
... trends, harnessing years of analytical knowledge Data and discussions to benefit your market research, analyses and decision making Tables, charts and lists to ... , meetings, presentations and selling pitches more influential. CNS Clinical Trials: World Market Prospects 2011-2026 shows you revenue trends, ...
December 2010
165 pages
US Pharmaceutical Market Outlook 2011-2021
US$ 2,325.00
... sectors. This report contains interviews with experts on prospects for the US market this decade, discussing matters such as: FDA funding and regulatory ... today, benefiting your analyses and commercial ideas. US Pharmaceutical Market Outlook 2011-2021 shows you revenue trends, opportunities and challenges ...
December 2010
170 pages
Bromides Applied in Pharmaceuticals Production in China
US$ 325.00
... the strong demand from production of bromides, China’s bromine industry had developed rapidly before 2007. Since 2008, China’s bromine output has ... a lot, which has largely impacted the production of bromides in China. Although China’s bromine and bromides industry has been heavily impacted by the global ...
December 2010
7 pages
UK Vitamin & Mineral Supplements Market Development Report
US$ 1,135.00
The UK vitamins and mineral supplements market research report analyses the historic and forecast levels of the market size. The report covers multi and single vitamins, including tonics, and dietary...
November 2010
60 pages
European Vaccine Markets
US$ 2,995.00
Price (Single User PDF): $2,995.00 Price (Global Site License): $5,990.00 The European vaccines market has demonstrated growth even through tough economic times. This has mainly been due to the intr...
November 2010
150 pages
Pharma Marketing in Latin America
US$ 395.00
Unified by geography, culture and language, Latin America nevertheless remains a marketing puzzle for the pharmaceutical industry. Although the Internet is increasing in popularity, it is available on...
November 2010
43 pages
Neurodegenerative Diseases: World Drug Market 2011-2026
US$ 2,325.00
... be left behind Our new report provides you with revenue forecasts, market share analyses, R&D pipeline developments and expert opinion. That way, you ... our report today, benefiting your analyses and commercial ideas. World Neurodegenerative Diseases: World Drug Market 2011-2026 shows you revenue trends, ...
November 2010
182 pages
Pharmaceutical Stability Testing: Commercial Prospects 2011-2025
US$ 2,325.00
... . This market constitutes one of the fastest growing sectors in the pharmaceutical and biotech sectors, with estimated revenues of $0.95bn (for technology ... report today, benefiting your analyses and commercial ideas. Pharmaceutical Stability Testing: Commercial Prospects 2011-2025 shows you revenue trends, ...
November 2010
132 pages
TOP 10 Drug Discovery Technologies – Strategic Analysis and Global Forecasts
US$ 5,650.00
Top 10 drug discovery technologies – strategic analysis and global forecasts (2010 to 2015) The top 10 drug discovery technologies play a vital role in the growth of the entire pharmaceutical ... of new blockbuster drugs is a major concern which the drug development companies are catering to by using these top technologies. The global top 10 drug discovery technologies market is expected ...
November 2010
311 pages
Booming US Generic Drug Market
US$ 1,000.00
Single User PDF Format: US$ 1,000.00 Multi-User License: US$ 1,600.00 Hard Copy: US$ 1,200.00 CD-ROM: US$ 1,200.00 The US represents one of the world’s largest economies. The countries per capita inc...
October 2010
50 pages
The 2011 Top Ten World’s Leading Pharmaceutical Companies
US$ 10,560.00
... To establish a comprehensive, factual, annually-updated and cost-effective information base on performance, capabilities, goals and strategies of the world’s leading pharmaceutical companies. To help current suppliers realistically assess their financial, marketing and technological capabilities vis-a-vis ...
October 2010
1200 pages
The 2011 Leading Pharmaceutical Companies Strategic Directions
US$ 1,480.00
... product development, and marketing objectives and strategies. Anticipated acquisitions, joint ventures and divestitures. The companies analyzed in the report: - AstraZeneca - Bristol-Myers Squibb - GlaxoSmithKline - Johnson & Johnson - Merck - ...
October 2010
45 pages
The 2011 Leading Pharmaceutical Companies Financial Analyses
US$ 1,480.00
... , geographic region, therapeutic category, and individual drug. Five-year sales and operating profit performance. The companies analyzed in the report: - AstraZeneca - Bristol-Myers Squibb - GlaxoSmithKline - Johnson & Johnson - Merck - Novartis ...
October 2010
130 pages
The 2011 Leading Pharmaceutical Companies Collaborative Arrangements
US$ 1,480.00
... , and licensing partners, both industrial and academic. Terms of collaborative agreements and specific products involved. The companies analyzed in the report: - AstraZeneca - Bristol-Myers Squibb - GlaxoSmithKline - Johnson & Johnson - Merck - ...
October 2010
200 pages
The 2011 Leading Pharmaceutical Companies Technological Know-How
US$ 1,480.00
... capabilities. Know-how in biotechnology and other pertinent fields. Proprietary technologies and patent litigations. The companies analyzed in the report: - AstraZeneca - Bristol-Myers Squibb - GlaxoSmithKline - Johnson & Johnson - Merck - ...
October 2010
50 pages
The 2011 Leading Pharmaceutical Companies Product Portfolio Analyses
US$ 1,480.00
... review of major ethical, OTC, and generic drugs. Most recent new drug introductions and indications. The companies analyzed in the report: - AstraZeneca - Bristol-Myers Squibb - GlaxoSmithKline - Johnson & Johnson - Merck - Novartis - ...
October 2010
275 pages
The 2011 Leading Pharmaceutical Companies Marketing Tactics
US$ 1,480.00
... force in the U.S., Europe, Asia, and other geographic regions. Distribution strategies. Major promotional tactics. The companies analyzed in the report: - AstraZeneca - Bristol-Myers Squibb - GlaxoSmithKline - Johnson & Johnson - Merck - Novartis ...
October 2010
60 pages
The 2011 Leading Pharmaceutical Companies Comparative Analysis
US$ 680.00
Global PDF: US$ 1,900.00 This report ranks the world’s major pharmaceutical companies according to the following criteria: Sales and market shares. Operating profit and margins. R&D expenditures and percent of sales. The companies analyzed in the report: - AstraZeneca - Bristol- ...
October 2010
Opthalmic Pharmaceutical Drugs: Market Research Report
US$ 4,500.00
This report analyzes the worldwide markets for Opthalmic Pharmaceutical Drugs in US$ million by the following Therapeutic Categories: Glaucoma, Anti-allergy, Anti- ... through 2015. A seven-year historic analysis is also provided for these markets. The report profiles 95 companies including many key and niche ...
October 2010
565 pages
Analgesics: Market Research Report
US$ 4,500.00
This report analyzes the worldwide markets for Analgesics in US$ Million by the following segments: Internal Analgesics, (Aspirin, Acetaminophen, Ibuprofen, and Others ( ... AG, Pfizer, Inc., Reckitt Benckiser Group Plc, and Sanofi Aventis S.A. Market data and analytics are derived from primary and secondary ...
October 2010
767 pages
Antibiotics: Market Research Report
US$ 4,500.00
This report analyzes the worldwide markets for Antibiotics in US$ Million by the following product segments: Penicillin, Cephalosporins, Macrolides, Quinolones, Carbapenems, and ... 2015. A seven-year historic analysis is also provided for these markets. The report profiles 197 companies including many key and ...
October 2010
850 pages
China Vaccine Industry Report, 2009-2010
US$ 1,900.00
Price:Hard Copy: US$ 1,900.00 PDF for Single User: US$ 2,000.00 PDF for Enterprisewide: US$ 3,000.00Being one of the world's largest vaccine producers, China not only has many vaccine companies, vari...
September 2010
111 pages
Global and China Biopharmaceutical Industry Report, 2010
US$ 2,000.00
In recent years, biopharmaceutical industry has been the fastest growing sector in the global pharmaceutical industry. From 1998 to 2009, the compound annual growth rate of biopharmaceutical industry...
September 2010
121 pages
Pharma Market Insights: Generics
US$ 1,645.00
FirstWord Market Intelligence Collections
Biosimilars. Biobetters. Branded and generic drugs. Specialty generics. Pay-for-delay.
Individually, they represent big questions for the...
September 2010
260 pages
Vitamin Deficiency Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Vitamin Deficiency Therapy Area Pipeline Report contains detailed information on the vitamin deficiency drug pipeline. This report provides insight into the pipeline status of...
September 2010
282 pages
Vaccines Manufacturing Technology and Services: Commercial Prospects 2010-2025
US$ 2,325.00
... 2025. This study provides data on the current and future of the vaccines market, covering sales and production capacity. We cover the overall world ... aid your decisions Our new report examines the vaccines manufacturing technology and services sector critically. We harness primary and secondary research to ...
September 2010
141 pages
